Large Cap - Spark Newswire

1 minute read

FDA Casts Doubts Over Roche’s Polivy Label Expansion For Untreated Lymphoma Setting

Today, 4:21 AM

Today, the FDA Oncologic Drugs Advisory Committee is discussing the supplemental marketing application for Polivy (polatuzumab vedotin-piiq) plus Rituxan (rituximab)…

RHHBF

1 minute read

AstraZenceca’s Tagrisso Shows Survival Benefit In Early-Stage Lung Cancer Settings

By Vandana Singh

Today, 4:21 AM

AstraZeneca Plc (NASDAQ:AZN) released topline data from the ADAURA Phase 3 trial demonstrating Tagrisso (osimertinib) demonstrated a statistically significant and clinically meaningful improvement…

AZN

1 minute read

AstraZeneca’s Immunotherapy Imfinzi Shows Improvement In Survival Chances In Lung Cancer Patients

By Vandana Singh

Today, 4:21 AM

In a trial, lung cancer patients treated with AstraZeneca plc’s (NASDAQ:AZN) immunotherapy Imfinzi (durvalumab) pre- and post-surgery lived significantly longer without the…

AZN

1 minute read

Analyst Downgrades Gossamer Bio As Merck’s Sotatercept Might Overshadow Seralutinib’s Success

By Vandana Singh

Today, 4:21 AM

Raymond James has downgraded Gossamer Bio Inc (NASDAQ:GOSS) to Market Perform from Outperform following the publication of sotatercept’s Phase 3 data in NEJM. …

GOSS

1 minute read

Medtronic Says PulseSelect Ablation System Demonstrates ‘Impressive Results’

By Vandana Singh

Today, 4:21 AM

Medtronic plc (NYSE:MDT) announced that its PulseSelect Pulsed Field Ablation (PFA) System exceeded its safety performance goal, with an adverse…

MDT

2 minute read

How Much Of Nvidia’s Stock Do You Need To Yield $200 Per Month?

By AJ Fabino

Today, 4:21 AM

Shares of Nvidia Corporation (NASDAQ: NVDA), a leading GPU company, has been on a roll in the past six months, climbing more than 110% from November lows, with 66% of those gains given to investors in 2023 alone.

NVDA

2 minute read

Intel Business Model ‘Structurally Misaligned With Industry Direction,’ Analyst Says

By AJ Fabino

Today, 4:21 AM

Intel Corporation (NASDAQ: INTC) is facing a tough challenge as its business model is said to be "structurally misaligned with industry direction," according to a bearish note issued Sunday by Bank of America Global Securities.

INTC

1 minute read

Eisai-Biogen Seek Complete FDA Approval For Its Second Alzheimer’s Treatment

By Vandana Singh

Today, 4:21 AM

The FDA has accepted Eisai Co Ltd (OTC:ESALY) and Biogen Inc’s (NASDAQ:BIIB) supplemental Biologics License Application (sBLA) for Leqembi (lecanemab-irmb) 100 mg/mL injection,…

BIIB

1 minute read

Data Shows Abbott’s TriClip System Superior To Other Medical Therapy In Heart Valve Disorder

By Vandana Singh

Today, 4:21 AM

Abbott Laboratories (NYSE:ABT) announced late-breaking data for the TriClip transcatheter edge-to-edge repair (TEER) system, a minimally invasive device designed specifically for…

ABT

1 minute read

Barron’s Top Weekend Stock Picks: Apple, First Solar, Deere And Why Tesla’s Stock Becoming Boring Isn’t Bad

By Michael Cohen

Today, 4:21 AM

Benzinga reviews this weekend's top stories covered by Barron's, here are the articles investors need to read.

AAPL